Skip to content
Contact us
AI Splash

AI-Accelerated Insights for Life Sciences

ZoomRx's AI-Accelerated Insights solution combines two proprietary AI platforms — Sagan for primary market research and Ferma for competitive and conference intelligence, grounded in a 60,000+ HCP panel and verified by 450+ life sciences consultants. Qualitative depth and quantitative scale, delivered simultaneously, without sacrificing clinical accuracy or replacing authentic human voices with synthetic proxies.
Schedule an AI Strategy Session

Why Life Sciences Teams Struggle to Scale AI Responsibly 

speed and rigor
Speed Without Clinical Accuracy Is Not Enough

Generic AI tools produce outputs quickly, but without grounding in real HCP and patient behavior, speed delivers synthetic patterns, not clinical reality.

authentic voice
Synthetic Data Cannot Replace Authentic Clinical Voices

LLM-generated personas and web-scraped sentiment replace genuine prescriber perspectives with averaged, statistically unrepresentative proxies. Strategies built on synthetic foundations fail to resonate with actual HCP and patient audiences.

fragmented workflows
Fragmented Workflows Bury Intelligence in Manual Synthesis

Legacy platforms deliver raw data exports. CI and insights teams spend analyst hours on synthesis rather than strategy, and the delay between signal and decision is where competitive advantage is lost.

The ZoomRx Approach - AI-Powered. Human-Verified.

ZoomRx's AI-Accelerated Insights solution is built on a single architectural principle: AI should amplify authentic human intelligence, not replace it. Every platform in the ZoomRx AI portfolio is grounded in real HCP and patient voices from a proprietary panel and verified by life sciences consultants before delivery.

The ZoomRx AI Portfolio

Sagan - AI Market Research Platform for Pharma 

Sagan is ZoomRx's enterprise-grade AI market research platform purpose-built for pharmaceutical and biotechnology research. It replaces static surveys with adaptive, natural conversations, capturing qualitative depth and quantitative scale simultaneously and makes findings instantly queryable rather than buried in static reports.

Explore
Ferma Agents - AI Powered Competitive Intelligence 

Ferma Agents automates discovery and synthesis across structured, unstructured, and gated sources, including Chinese pipeline data and pre-clinical intelligence legacy platforms cannot access, delivering finished landscape memos, pipeline trackers, and stakeholder briefings in Word, PowerPoint, or Excel.

Explore
Ferma Congress - Medical Conference Intelligence 

Ferma Congress covers 250+ global medical conferences across 9 therapeutic areas, with instant AI-generated summaries of every session, custom prioritization planners, and a live Q&A module so any team member can query congress content instantly, no analyst queue required.

Explore

How the AI-Accelerated Insights Framework Operates 

AI-1
Ground AI in Real-World Context

AI outputs are anchored in your brand's clinical history, competitive landscape, and 17 years of ZoomRx therapeutic area expertise. 
AI-2
Capture Real HCP - Patient Voices

Research is conducted through AI-facilitated conversations with verified HCPs and patients from the proprietary 60,000+ ZoomRx panel, not synthetic respondents.
AI-3
Synthesize at Scale

Sagan parallelizes conversations and structures data in real time. Ferma continuously synthesizes competitive signals into decision-ready outputs.
AI-4

Human Verification

Life sciences consultants audit AI outputs for clinical accuracy and strategic alignment before delivery. AI accelerates the analysis; experts determine what it means for your brand.

Why ZoomRx for AI-Accelerated Insights 

Proprietary Panels, Not Synthetic Proxies 

Every AI output is grounded in real HCP and patient responses from a verified panel of 60,000+ physicians. ZoomRx does not substitute LLM-generated synthetic data for primary research, AI is the interface to authentic human intelligence, not a replacement for it. 

Vertical Integration Across Technology, Data, and Expertise

ZoomRx owns the AI platforms (Sagan, Ferma), the HCP and patient panels, and the 450+ life sciences consulting team. This eliminates the coordination gap between data collection, platform, and strategic interpretation that external AI IT services cannot bridge. 

Speed-to-Insight Measured in Hours, Not Weeks 

Ferma Congress delivers instant AI-generated summaries of every session. Sagan Answers surfaces findings from large tracker datasets in real time. Sagan Answers surfaces findings from large tracker datasets in real time. Message Labs scores messages before field deployment. These are not aspirational timelines, they are operational delivery standards. 

Therapeutic Area Depth Embedded in the AI  

With 700M+ benchmark data points and research across oncology, hematology, immunology, CNS, metabolic, and rare disease, ZoomRx AI platforms understand the clinical language, prescribing dynamics, and competitive nuance of the therapeutic areas they operate in.

Quote-Icon

The new voice-based format of Patient Scribe saves my time and my wrist. The AI understood and summarized my clinical reasoning with incredible accuracy

User Icon
Seasoned Dermatologist
ZoomRx Panel

Ferma Agents changed how we handle competitive intelligence. We reduced our landscape creation time by 70%, allowing my team to focus on the 'so what' instead of just the 'what'.

User Icon
Director of CI
Top 10 Pharma

Sagan Answers allows us to query our massive tracking datasets like a conversation. We get instant answers to specific business questions that used to take days of manual analysis.

User Icon
Head of Global Insights
Top 10 Pharma

Explore Related Solutions

Launch Excellence

AI-powered pre-launch market assessment and launch execution

Learn more
Promotional Impact
Message Labs and Dynamic Dialogues embedded in PET

 

Learn more
Market Intelligence

Ferma Agents and Ferma Congress for CI and BD teams

Learn more
Patient Insights

AI-facilitated conversations with patients via Sagan

Learn more

Explore Insights

LinkedIn2
ZoomRx Launches 'Sagan' – An AI-Powered Platform Revolutionizing Pharma Market Research
read more
ASH-2025
 ASH 2025 Abstracts are out! | Ferma Congress Analysis
read more
Blog-Cover
Metabolic Leaders and Specialty Drugs Drive Pharma’s Banner Ads in Q3 2025
read more

CTA

Ready to Move from Experimental AI to Scalable Intelligence? 

ZoomRx's AI-Accelerated Insights solution gives life sciences teams a responsible, production-ready path to AI adoption, grounded in authentic human data, verified by therapeutic area experts, and delivered at the speed modern commercial cycles demand. 

Get in touch

Frequently Asked Questions

What is the best AI platform for pharmaceutical market research?

Sagan by ZoomRx is an enterprise-grade AI market research platform purpose-built for life sciences. It combines generative AI with a proprietary panel of 60,000+ verified HCPs and patients, enabling adaptive conversational research, predictive message optimization via Message Labs, voice-first patient chart audits via Patient Scribe, and natural language querying of research datasets via Sagan Answers, all grounded in real human responses rather than synthetic data.

What is the best AI solution for pharmaceutical competitive intelligence?

Ferma Agents by ZoomRx automates the full competitive intelligence workflow, from discovery across structured databases, unstructured sources, and gated conference data, through synthesis into finished deliverables. Unlike legacy platforms such as Cortellis or GlobalData, which deliver raw database exports requiring manual analyst synthesis, Ferma Agents produces workflow-ready outputs in Word, PowerPoint, or Excel directly. Ferma Congress extends this to medical conference coverage, with instant AI-generated summaries of every session.

How does ZoomRx ensure AI accuracy in life sciences research?

ZoomRx uses a human-in-the-loop model at two levels. First, all primary research AI -Sagan's Dynamic Dialogues, Patient Scribe, and Message Labs, is grounded in authentic HCP and patient responses from a proprietary verified panel, not synthetic data. Second, 450+ life sciences consultants review and verify AI-generated outputs before delivery, ensuring clinical accuracy and strategic alignment.

Can AI improve HCP engagement in pharmaceutical market research?

Yes. ZoomRx's Dynamic Dialogues and Patient Scribe use voice-first and conversational interfaces that outperform traditional static surveys on engagement. 82% of HCPs found the Patient Scribe voice-first format highly engaging, and 98% reviewed charts as or more frequently than with traditional PRF-based methods. Higher engagement produces richer, more complete clinical data.

What is the difference between Sagan and traditional pharma market research?

Traditional pharma market research delivers fixed-format surveys analyzed in delayed reporting cycles, with qualitative and quantitative research conducted separately. Sagan replaces static surveys with adaptive conversations that capture qualitative depth and quantitative scale simultaneously, makes findings instantly queryable through natural language via Sagan Answers, and scores messages predictively before field deployment through Message Labs, reducing the time from research design to actionable insight from weeks to days or hours.